Skip to main content

September/October 2009, Vol 2, No 6

Cost-Sharing Enhances Cost Control

H.E. Frech, III, PhD

Health Policy and Reform

Healthcare Reform, Classicism, and How We Treat the Elderly: The Politics of Epidemiology

Robert E. Henry

Industry Trends

Can Generics Help Heal Our Ailing Healthcare System?

Dalia Buffery, MA, ABD

Predictive and Prognostic Models: Implications for Healthcare Decision-Making in a Modern Recession

F. Randy Vogenberg, PhD, FASHP

Stakeholder Perspective

Potential Benefits of Prediction Models from Large Electronic Databases

by Jason Roy, PhD

Estimates of Commercial Population at High Risk for Cardiovascular Events: Impact of Aggressive Cholesterol Reduction

Kathryn Fitch, RN, MEd, Sara W. Goldberg, FSA, MAAA, Kosuke Iwasaki, FIAJ, MAAA, Bruce S. Pyenson, FSA, MAAA, Andreas Kuznik, PhD, Henry A. Solomon, FACP, FACC

Stakeholder Perspective

The 10,000-Life Measure Shows Real-World Costs of Disease Burden and Interventions on a Population

by David Williams

Impact of Prescription Benefit Coverage Limits on Sevelamer Hydrochloride Adherence for Patients with ESRD

Bharati Bhardwaja, PharmD, BCPS, Nikki Carroll, MS, Eli Korner, PharmD, Kavita V. Nair, PhD

Stakeholder Perspective

Balancing Horizontal and Vertical Equity within Managed Health Plans Drug Benefit

by Jack E. Fincham, PhD, RPh

Private Health Plans Perspectives: Electronic Personal Health Records and Electronic Prescribing

Nancy M. McGee, JD, MPH, Gene Reeder, RPh, PhD, Timothy S. Regan, BPharm, RPh, CPh, J.D. Kleinke, Steve Arnold, MD, MS, MBA, CPE

Stakeholder Perspective

Electronic PHRs and e-Prescribing: Not Quite There Yet

by Gary M. Owens, MD

Results 1 - 7 of 7